Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 60/100

Failure Rate

9.1%

1 terminated/withdrawn out of 11 trials

Success Rate

85.7%

-0.8% vs industry average

Late-Stage Pipeline

1 trials in Phase 3/4

Results Transparency

0 of 6 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A

9(90.0%)

Phase 3

1(10.0%)

10Total

N/A(9)

Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (11)

Showing 11 of 11 trials

NCT05513261Not ApplicableCompleted

Clinical Validation of PolyDeep: an Artificial Intelligence-based Computer-aided Polyp Detection (CADe) and Characterization (CADx) System. Polydeep Advance 3

Role: collaborator

NCT05514301Not ApplicableCompleted

Clinical Validation of Polydeep: an Artificial Intelligence-based Computer-aided Polyp Detection (CADe) and Characterization (CADx) System

Role: collaborator

NCT05512793Not ApplicableCompleted

Clinical Validation of PolyDeep: an Artificial Intelligence-based Computer-aided Polyp Detection (CADe) and Characterization (CADx) System. Polydeep Advance 2.

Role: collaborator

NCT06791616Not ApplicableNot Yet Recruiting

Surveillance Intervals After Piecemeal Resection of Non-pedunculated Colorectal Lesions ≥20mm

Role: lead

NCT06625788Not Yet Recruiting

Clinical and Endoscopic Characterization of Patients With Multiple Colorectal Adenomas: A Multicenter Study in Spain (ESPAPOLYP Study)

Role: lead

NCT05663788Not ApplicableRecruiting

Web-based Learning Module on Optical Diagnosis of Early Colorectal Cancer

Role: collaborator

NCT04673136Not ApplicableCompleted

Usefulness of GI-GENIUS in FIT-based Colorectal Cancer Screening Program.